Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

NCT02744092 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

811

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Venous Thromboembolism
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Blood Clot

Interventions

DRUG: Rivaroxaban
DRUG: Apixaban
DRUG: Edoxaban
DRUG: Dabigatran
DRUG: Warfarin
DRUG: Dalteparin
DRUG: Enoxaparin
DRUG: Fondaparinux

Sponsor

Alliance Foundation Trials, LLC.

Collaborators

[object Object]